2026年3月最新《新锐期刊分区表》数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
![]() |
体验更多LetPub AI科研工具 >> | |
| 近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 新 聚合物期刊JPM征稿|IF持续上升 + APC折扣 | 热 Springer Nature特刊征稿 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | CANCER CELL CANCER CELL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 9.8
51人评分
我要评分
声誉 10.0 影响力 9.7 速度 9.4 | |||||||||||||||||||||||||||||||
| 期刊ISSN | 1535-6108 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||||||||||||
| E-ISSN | 1878-3686 | |||||||||||||||||||||||||||||||
| 2024-2025最新影响因子 (数据来源于搜索引擎) | 44.5 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日:55.79 | |||||||||||||||||||||||||||||||
| 2024-2025自引率 | 1.3%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
| 五年影响因子 | 47.2 | |||||||||||||||||||||||||||||||
| JCI期刊引文指标 | 8.07 | |||||||||||||||||||||||||||||||
| h-index | 295 | |||||||||||||||||||||||||||||||
| CiteScore ( 2026年6月最新版) |
| |||||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||||
| 期刊官方网站 | http://www.cell.com/cancer-cell/home | |||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/CANCER-CELL | |||||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Reactivating p53 mutants selectively in patients Author: Chen, Shuo; Shepard, H. Michael; Lu, Min Journal: CANCER CELL. 2026; Vol. 44, Issue 4, pp. 715-717. DOI: 10.1016/j.ccell.2026.03.009 Lipid oxidation reprogramming in cancer-associated fibroblasts enhances CD8+T cell cytotoxicity and therapeutic response Author: Ma, Zikun; Wang, Yuzhao; Wang, Weikai; Sun, Wanyang; Wang, Rong; Ding, Xue; Chen, Zibin; Li, Xiangdong; Li, Zhiyong; Ye, Yunlin; Mao, Yize; Yin, Jianhua; Li, Guibo; He, Rong-Rong; Liang, Xiaoyu; Liu, Zhuowei Journal: CANCER CELL. 2026; Vol. 44, Issue 4, pp. 743-759. DOI: 10.1016/j.ccell.2026.01.012 Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer Author: Zhao, Qi; Huang, Runjie; Wang, Chaoye; Hu, Jiajia; Nie, Runcong; Jian, Rui; Wang, Yingnan; Wang, Dongfang; Liang, Chengcai; Chen, Yanxing; Chen, Yukun; Wu, Chenyi; Zhang, Jinling; Chen, Jiaying; An, Nan; Jin, Ying; Guan, Wenlong; Wang, Zixian; Li, Yuanfang; Sun, Xiaowei; Chen, Yingbo; Wang, Wei; Qiu, Haibo; Zhou, Zhiwei; Wang, Feng; Xu, Rui-Hua; Yuan, Shuqiang Journal: CANCER CELL. 2026; Vol. 44, Issue 4, pp. 809-830. DOI: 10.1016/j.ccell.2026.01.015 HS-20093, a B7-H3-targeted antibody-drug conjugate in lung cancer: Results from the ARTEMIS-001 phase 1a/b trial Author: Duan, Jianchun; Sun, Yuping; Wang, Qiming; Xing, Ligang; Wu, Lin; Han, Liang; Chen, Jianhua; Liu, Baogang; Lu, Ping; Shi, Huaqiu; Yu, Xinmin; Zhang, Junhong; Zhang, Guoping; Hu, Yanping; Cheng, Ying; Sun, Hongmei; Yang, Haihua; Zhang, Zhiye; Ning, Fangling; He, Zhiyong; Yao, Wenxiu; Dong, Yiwei; Zhang, Min; Song, Baili; Zhou, Yuanfeng; Mao, Xiangru; Liu, Qingyuan; Wang, Jie Journal: CANCER CELL. 2026; Vol. 44, Issue 4, pp. 846-857. DOI: 10.1016/j.ccell.2026.02.006 | |||||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CANCER CELL的语言要求,还能让CANCER CELL编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CANCER CELL编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||||||||
| 通讯方式 | CELL PRESS, 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, USA, MA, 02139 | |||||||||||||||||||||||||||||||
| 出版商 | Cell Press | |||||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||||||||
| 出版年份 | 2002 | |||||||||||||||||||||||||||||||
| 年文章数 | 112点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
| Gold OA文章占比 | 31.56% | |||||||||||||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 93.75% | |||||||||||||||||||||||||||||||
| WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1535-6108%5BISSN%5D | |||||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: 偏慢,4-8周 | |||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验: 极难 | |||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在CANCER CELL顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Reactivating p53 mutants selectively in patients Author: Chen, Shuo; Shepard, H. Michael; Lu, Min Journal: CANCER CELL. 2026; Vol. 44, Issue 4, pp. 715-717. DOI: 10.1016/j.ccell.2026.03.009 PubMed DOI |
| 2. | Lipid oxidation reprogramming in cancer-associated fibroblasts enhances CD8+T cell cytotoxicity and therapeutic response Author: Ma, Zikun; Wang, Yuzhao; Wang, Weikai; Sun, Wanyang; Wang, Rong; Ding, Xue; Chen, Zibin; Li, Xiangdong; Li, Zhiyong; Ye, Yunlin; Mao, Yize; Yin, Jianhua; Li, Guibo; He, Rong-Rong; Liang, Xiaoyu; Liu, Zhuowei Journal: CANCER CELL. 2026; Vol. 44, Issue 4, pp. 743-759. DOI: 10.1016/j.ccell.2026.01.012 PubMed DOI |
| 3. | Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer Author: Zhao, Qi; Huang, Runjie; Wang, Chaoye; Hu, Jiajia; Nie, Runcong; Jian, Rui; Wang, Yingnan; Wang, Dongfang; Liang, Chengcai; Chen, Yanxing; Chen, Yukun; Wu, Chenyi; Zhang, Jinling; Chen, Jiaying; An, Nan; Jin, Ying; Guan, Wenlong; Wang, Zixian; Li, Yuanfang; Sun, Xiaowei; Chen, Yingbo; Wang, Wei; Qiu, Haibo; Zhou, Zhiwei; Wang, Feng; Xu, Rui-Hua; Yuan, Shuqiang Journal: CANCER CELL. 2026; Vol. 44, Issue 4, pp. 809-830. DOI: 10.1016/j.ccell.2026.01.015 PubMed DOI |
| 4. | HS-20093, a B7-H3-targeted antibody-drug conjugate in lung cancer: Results from the ARTEMIS-001 phase 1a/b trial Author: Duan, Jianchun; Sun, Yuping; Wang, Qiming; Xing, Ligang; Wu, Lin; Han, Liang; Chen, Jianhua; Liu, Baogang; Lu, Ping; Shi, Huaqiu; Yu, Xinmin; Zhang, Junhong; Zhang, Guoping; Hu, Yanping; Cheng, Ying; Sun, Hongmei; Yang, Haihua; Zhang, Zhiye; Ning, Fangling; He, Zhiyong; Yao, Wenxiu; Dong, Yiwei; Zhang, Min; Song, Baili; Zhou, Yuanfeng; Mao, Xiangru; Liu, Qingyuan; Wang, Jie Journal: CANCER CELL. 2026; Vol. 44, Issue 4, pp. 846-857. DOI: 10.1016/j.ccell.2026.02.006 PubMed DOI |
| 5. | B cells disrupt tertiary lymphoid structure formation and suppress anti-tumor immunity Author: Chen, Changhao; An, Mingjie; Zheng, Hanhao; Pang, Mingrui; Li, Yuanlong; Diao, Xiayao; Luo, Yuming; Lin, Yan; Liu, Daiyin; Li, Wenjie; Chen, Jiancheng; Liu, Zhicong; Chen, Yuanlong Zewei; Hu, Anhong; Zhong, Wenlong; Huang, Jian; Lin, Tianxin Journal: CANCER CELL. 2026; Vol. 44, Issue 3, pp. 551-566. DOI: 10.1016/j.ccell.2025.12.011 PubMed DOI |
| 6. | Chemotherapy triggers immune evasion by fostering LEPR plus Kupffer cell differentiation in liver metastases Author: Wang, Xuege; Pan, Qiang; Li, Yaqi; Li, Ni; Guo, Jiacheng; Gu, Yongqiang; Zhang, Guoying; Lian, Yannan; Liu, Hailong; Cao, Limin; Zhang, Wei; Lin, Naiheng; Xu, Beitao; Jin, Zige; Zeng, Xin; Zang, Yi; Cheng, Xiaoyan; Xiao, Hui; Chen, Sujun; Lin, Moubin; Wang, Guihua; Peng, Junjie; Xiao, Yichuan; Qin, Jun Journal: CANCER CELL. 2026; Vol. 44, Issue 3, pp. 658-675. DOI: 10.1016/j.ccell.2026.01.010 PubMed DOI |
| 7. | Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage Author: Li, Lei; Ye, Qi; Ma, Jinlu; Wang, Zixi; Liu, Tianjie; Lei, Yuzeshi; Lu, Mingming; Kang, Jialu; Xiang, Haohan; Li, Buyun; Xu, Shan; Wang, Ke; Chen, Yule; Chen, Jiaqi; Ma, Bohan; Huang, Wenyue; Cai, Mengjiao; Wu, Nan; Li, Yanqiang; An, Jiale; Jiang, Chongming; Ye, Rui; Liu, Jing; Lin, Steven H.; Gao, Yang; Ma, Jian Journal: CANCER CELL. 2026; Vol. 44, Issue 2, pp. -. DOI: 10.1016/j.ccell.2025.12.013 PubMed DOI |
| 8. | Single-cell screens identify ADAM12 as a fibroblast checkpoint impeding anti-tumor immunity Author: Li, Jianan; Liu, Huilan; Guo, Qile; Zhang, Yiying; Li, Jiaxin; Diao, Tian; Zheng, Liangtao; Deng, Zenghua; Yang, Yu; Chen, Xueyan; Qin, Shishang; Li, Jinhu; He, Yao; He, Wanzhuo; Liu, Dongfang; Bo, Yufei; Liu, Chang; Lu, Huinan; Fan, Hongtao; Hu, Xueda; Peng, Jirun; Zhu, Linnan; Xi, Jianzhong Jeff; Wang, Dongfang; Zhang, Zemin Journal: CANCER CELL. 2026; Vol. 44, Issue 2, pp. -. DOI: 10.1016/j.ccell.2025.12.018 PubMed DOI |
| 9. | Integrative proteogenomic analysis provides molecular insights and clinical significance in gallbladder cancer Author: Fu, Zile; Song, Yuanli; Liu, Fen; Chen, Lv; Cai, Shangli; Cui, Peng; Wang, Guoqiang; Xie, Wenchuan; Zhang, Shu; Ding, Li; Wang, Pei; Zhang, Bing; Rodriguez, Henry; Feng, Feiling; Zhang, Xufeng; Gaog, Wei; Gao, Qiang; Gao, Daming; Zhou, Hu; Fan, Jia Journal: CANCER CELL. 2026; Vol. 44, Issue 2, pp. -. DOI: 10.1016/j.ccell.2025.12.014 PubMed DOI |
| 10. | Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2-breast cancer: The LINUXtrial Author: Fan, Lei; Zhang, Wen-Juan; Li, Hui-Ping; Zeng, Xiao-Hua; Teng, Yue-E; Gong, Yue; Jin, Xi; Zhao, Shen; Sun, Tao; Chen, Wen-Yan; Wang, Shu-Sen; Yang, Jin; Zhuang, Zhi-Gang; Ni, Su-Jie; He, Zhi-Xian; Fu, De-Yuan; Song, Chuan-Gui; Lv, Zheng; Liang, Qian-Nan; Yu, Bao-Hua; Shi, Jing; Wang, Nan; Liang, Xin-Rui; Zhang, Ning-Ning; Wang, Yun; Ji, Peng; Liu, Xi-Yu; Chen, Li; He, Min; Liu, Yin; Sui, Xin-Yi; Ma, Lin-Xiaoxi; Zhu, Xiu-Zhi; Yang, Fan; Ge, Li-Ping; Wu, Song-Yang; Wu, Jiong; Yu, Ke-Da; Liu, Guang-Yu; Hu, Xin; Shen, Yu; Pang, Zheng; Wang, Jian-Fei; Liang, Fei; Yang, Wen-Tao; Wang, Zhong-Hua; Jiang, Yi-Zhou; Shao, Zhi-Ming Journal: CANCER CELL. 2026; Vol. 44, Issue 2, pp. -. DOI: 10.1016/j.ccell.2025.11.003 PubMed DOI |
|
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共59条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室